Gujarat Alkalies Approves ₹17.70 Dividend, Sanctions New Hydrogen Peroxide Plant

Gujarat Alkalies and Chemicals Ltd (GACL) announced its audited financial results for the year ended March 31, 2026, recommending a final dividend of ₹17.70 per share. The company also approved a significant investment of ₹67 crore for a new 5,000 TPA High Purity Grade Hydrogen Peroxide plant at Dahej.

Reader Takeaway: Dividend payout offers shareholder returns, while new plant signals focus on electronics sector growth.

What just happened

GACL's board approved its audited standalone and consolidated financial results for the fiscal year ending March 31, 2026. Key financial highlights include standalone revenue from operations of ₹4,358.08 crore and a standalone profit of ₹20.84 crore. Consolidated financials reported a net loss of ₹(2.41) crore.

The board recommended a final dividend of ₹17.70 per equity share (face value ₹10). This dividend is subject to shareholder approval.

Furthermore, the company sanctioned a capital expenditure of ₹67 crore to set up a 5,000 TPA High Purity Grade Hydrogen Peroxide plant at Dahej, Gujarat. This facility aims to serve the semiconductor, solar cell, and advanced electronics industries.

Why this matters

The recommended dividend provides a direct return to shareholders. The investment in the high-purity hydrogen peroxide plant signals GACL's strategic move to tap into high-growth sectors like electronics and semiconductors, potentially boosting future revenues and margins.

However, the consolidated net loss, despite standalone profitability, is primarily due to accumulated losses of ₹633.31 crore in the GACL-NALCO joint venture. This JV performance is a key concern impacting overall company results.

The backstory

For the financial year 2026, GACL's standalone revenue from operations grew by 7% to ₹4,358.08 crore compared to ₹4,072.91 crore in FY2025. Standalone profit for the period also increased by 31.73% to ₹20.84 crore from ₹15.82 crore.

The company also reported an increase in its renewable energy share to 35.7% in FY2026, up from 29.7% in FY2025.

What changes now

Shareholders await the Annual General Meeting for final dividend approval. The ₹67 crore investment in the hydrogen peroxide plant will commence, with expected commissioning and contribution to sales revenue in the coming years. The company also plans to commission an HCl Synthesis Unit, a Chlorotoluene Downstream Plant, and renewable energy projects in FY 2026-27.

Risks to watch

The primary concern remains the significant accumulated losses in the GACL-NALCO joint venture, which continue to exert a drag on consolidated financials. Management's ability to turn around or mitigate these JV losses is crucial.

Peer comparison

While specific peer financial data for FY2026 is not provided in the filing, GACL operates in the chlor-alkali and other chemical segments. Competitors include companies like DCM Shriram, Reliance Industries (chemical division), and Tata Chemicals. GACL's strategic focus on high-purity chemicals for electronics differentiates it, while its renewable energy push aligns with broader industry trends.

Context metrics (time-bound)

• Standalone Revenue from Operations (FY2026): ₹4,358.08 crore (+7.00% YoY)
• Standalone Profit for the period (FY2026): ₹20.84 crore (+31.73% YoY)
• Consolidated Net Loss (FY2026): ₹(2.41) crore
• Dividend per Equity Share recommended: ₹17.70
• Hydrogen Peroxide Plant Capex: ₹67 crore
• JV Accumulated Losses (as at 31/03/2026): ₹633.31 crore
• Renewable Energy Share (FY2026): 35.7%

What to track next

Investors should closely track the progress and commissioning of the new hydrogen peroxide plant, the impact of upcoming projects like the HCl Synthesis Unit and Chlorotoluene Downstream Plant, and the financial performance of the GACL-NALCO joint venture on the consolidated results.